Hematologic NeoplasmsBone Marrow TransplantationBone MarrowHematopoietic Stem Cell TransplantationTransplantation, HomologousMultiple MyelomaBone Marrow CellsNeoplasmsStem CellsGraft vs Host DiseaseTransplantation, AutologousStem Cell TransplantationHematopoietic Stem CellsBone and BonesTissue DonorsCytomegalovirus InfectionsTransplantation ConditioningWhole-Body IrradiationLeukemiaImmunocompromised HostGraft SurvivalAnemia, AplasticHistocompatibility TestingTransplantationImmunosuppressive AgentsOpportunistic InfectionsTreatment OutcomeHistocompatibilityMycosesRetrospective StudiesKidney TransplantationTime FactorsCytomegalovirusPeripheral Blood Stem Cell TransplantationGraft RejectionRecurrenceTransplantation ChimeraAspergillosisCell DifferentiationImmunosuppressionBone Marrow PurgingLeukemia, Myeloid, AcuteLeukemia, Myelogenous, Chronic, BCR-ABL PositiveEmbryonic Stem CellsCyclosporineBusulfanPrecursor Cell Lymphoblastic Leukemia-LymphomaTransplantsSurvival AnalysisHematologic DiseasesFatal OutcomeCombined Modality TherapyHematopoiesisAdult Stem CellsMice, Inbred C57BLBone Marrow DiseasesBone RemodelingGanciclovirBone Marrow ExaminationAcute DiseaseSurvival RateHepatic Veno-Occlusive DiseaseBone Marrow NeoplasmsCyclophosphamideCells, CulturedFollow-Up StudiesFlow CytometryHLA AntigensAntigens, CD34Polymerase Chain ReactionLymphocyte DepletionHematopoietic Stem Cell MobilizationAntifungal AgentsPneumonia, ViralHerpesvirus 6, HumanPluripotent Stem CellsAntiviral AgentsStem Cell NicheColony-Forming Units AssayMesenchymal Stem Cell TransplantationBK VirusAntineoplastic Combined Chemotherapy ProtocolsCystitisProspective StudiesDisease-Free SurvivalT-LymphocytesMyelodysplastic SyndromesRadiation ChimeraRisk FactorsBone DensityLeukemia, MyeloidLymphoma, Non-HodgkinPostoperative ComplicationsNeutropeniaTransplantation, IsogeneicRemission InductionPrognosisMesenchymal Stromal CellsCell LineageLeukocyte Transfusion